N-cyclohexyl-1-[6-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]piperidin-4-amine;N-cyclohexyl-1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]piperidin-4-amine;2-[[1-[6-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]piperidin-4-yl]amino]cyclohexan-1-ol;1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]-N-(oxan-4-yl)piperidin-4-amine;2-[[1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]piperidin-4-yl]amino]cyclohexan-1-ol

C116H147N25O8 — CID 158330098

IUPACN-cyclohexyl-1-[6-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]piperidin-4-amine;N-cyclohexyl-1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]piperidin-4-amine;2-[[1-[6-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]piperidin-4-yl]amino]cyclohexan-1-ol;1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]-N-(oxan-4-yl)piperidin-4-amine;2-[[1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]piperidin-4-yl]amino]cyclohexan-1-ol
SMILESCc1ccc2nc(N3CCC(NC4CCCCC4)CC3)c(-c3nc(C)no3)cc2c1.Cc1ccc2nc(N3CCC(NC4CCCCC4O)CC3)c(-c3nc(C)no3)cc2c1.Cc1noc(-c2cc3ccccc3nc2N2CCC(NC3CCCCC3)CC2)n1.Cc1noc(-c2cc3ccccc3nc2N2CCC(NC3CCCCC3O)CC2)n1.Cc1noc(-c2cc3ccccc3nc2N2CCC(NC3CCOCC3)CC2)n1
InChIInChI=1S/C24H31N5O2.C24H31N5O.C23H29N5O2.C23H29N5O.C22H27N5O2/c1-15-7-8-20-17(13-15)14-19(24-25-16(2)28-31-24)23(27-20)29-11-9-18(10-12-29)26-21-5-3-4-6-22(21)30;1-16-8-9-22-18(14-16)15-21(24-25-17(2)28-30-24)23(27-22)29-12-10-20(11-13-29)26-19-6-4-3-5-7-19;1-15-24-23(30-27-15)18-14-16-6-2-3-7-19(16)26-22(18)28-12-10-17(11-13-28)25-20-8-4-5-9-21(20)29;1-16-24-23(29-27-16)20-15-17-7-5-6-10-21(17)26-22(20)28-13-11-19(12-14-28)25-18-8-3-2-4-9-18;1-15-23-22(29-26-15)19-14-16-4-2-3-5-20(16)25-21(19)27-10-6-17(7-11-27)24-18-8-12-28-13-9-18/h7-8,13-14,18,21-22,26,30H,3-6,9-12H2,1-2H3;8-9,14-15,19-20,26H,3-7,10-13H2,1-2H3;2-3,6-7,14,17,20-21,25,29H,4-5,8-13H2,1H3;5-7,10,15,18-19,25H,2-4,8-9,11-14H2,1H3;2-5,14,17-18,24H,6-13H2,1H3
InChIKeyGPWYPSHNSDGDIQ-UHFFFAOYSA-N
MW2019.62 g/mol
LogP19.83
Rot. Bonds20

About N-cyclohexyl-1-[6-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]piperidin-4-amine;N-cyclohexyl-1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]piperidin-4-amine;2-[[1-[6-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]piperidin-4-yl]amino]cyclohexan-1-ol;1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]-N-(oxan-4-yl)piperidin-4-amine;2-[[1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]piperidin-4-yl]amino]cyclohexan-1-ol

N-cyclohexyl-1-[6-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]piperidin-4-amine;N-cyclohexyl-1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]piperidin-4-amine;2-[[1-[6-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]piperidin-4-yl]amino]cyclohexan-1-ol;1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]-N-(oxan-4-yl)piperidin-4-amine;2-[[1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]piperidin-4-yl]amino]cyclohexan-1-ol (PubChem CID 158330098) has the molecular formula C116H147N25O8 and a molecular weight of 2019.62 g/mol. Its IUPAC name is N-cyclohexyl-1-[6-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]piperidin-4-amine;N-cyclohexyl-1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]piperidin-4-amine;2-[[1-[6-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]piperidin-4-yl]amino]cyclohexan-1-ol;1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]-N-(oxan-4-yl)piperidin-4-amine;2-[[1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]piperidin-4-yl]amino]cyclohexan-1-ol.

Molecular Properties

Compound NameN-cyclohexyl-1-[6-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]piperidin-4-amine;N-cyclohexyl-1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]piperidin-4-amine;2-[[1-[6-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]piperidin-4-yl]amino]cyclohexan-1-ol;1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]-N-(oxan-4-yl)piperidin-4-amine;2-[[1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]piperidin-4-yl]amino]cyclohexan-1-ol
PubChem CID158330098
Molecular FormulaC116H147N25O8
Molecular Weight2019.62 g/mol
Exact Mass2018.19
IUPAC NameN-cyclohexyl-1-[6-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]piperidin-4-amine;N-cyclohexyl-1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]piperidin-4-amine;2-[[1-[6-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]piperidin-4-yl]amino]cyclohexan-1-ol;1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]-N-(oxan-4-yl)piperidin-4-amine;2-[[1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]piperidin-4-yl]amino]cyclohexan-1-ol
SMILESCc1ccc2nc(N3CCC(NC4CCCCC4)CC3)c(-c3nc(C)no3)cc2c1.Cc1ccc2nc(N3CCC(NC4CCCCC4O)CC3)c(-c3nc(C)no3)cc2c1.Cc1noc(-c2cc3ccccc3nc2N2CCC(NC3CCCCC3)CC2)n1.Cc1noc(-c2cc3ccccc3nc2N2CCC(NC3CCCCC3O)CC2)n1.Cc1noc(-c2cc3ccccc3nc2N2CCC(NC3CCOCC3)CC2)n1
InChIInChI=1S/C24H31N5O2.C24H31N5O.C23H29N5O2.C23H29N5O.C22H27N5O2/c1-15-7-8-20-17(13-15)14-19(24-25-16(2)28-31-24)23(27-20)29-11-9-18(10-12-29)26-21-5-3-4-6-22(21)30;1-16-8-9-22-18(14-16)15-21(24-25-17(2)28-30-24)23(27-22)29-12-10-20(11-13-29)26-19-6-4-3-5-7-19;1-15-24-23(30-27-15)18-14-16-6-2-3-7-19(16)26-22(18)28-12-10-17(11-13-28)25-20-8-4-5-9-21(20)29;1-16-24-23(29-27-16)20-15-17-7-5-6-10-21(17)26-22(20)28-13-11-19(12-14-28)25-18-8-3-2-4-9-18;1-15-23-22(29-26-15)19-14-16-4-2-3-5-20(16)25-21(19)27-10-6-17(7-11-27)24-18-8-12-28-13-9-18/h7-8,13-14,18,21-22,26,30H,3-6,9-12H2,1-2H3;8-9,14-15,19-20,26H,3-7,10-13H2,1-2H3;2-3,6-7,14,17,20-21,25,29H,4-5,8-13H2,1H3;5-7,10,15,18-19,25H,2-4,8-9,11-14H2,1H3;2-5,14,17-18,24H,6-13H2,1H3
InChIKeyGPWYPSHNSDGDIQ-UHFFFAOYSA-N
XLogP19.83
TPSA385.09 Ų
H-Bond Donors7
H-Bond Acceptors33
Rotatable Bonds20
Heavy Atoms149
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002019.62
LogP ≤ 519.83
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 1033

Analyze N-cyclohexyl-1-[6-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]piperidin-4-amine;N-cyclohexyl-1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]piperidin-4-amine;2-[[1-[6-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]piperidin-4-yl]amino]cyclohexan-1-ol;1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]-N-(oxan-4-yl)piperidin-4-amine;2-[[1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]piperidin-4-yl]amino]cyclohexan-1-ol with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-cyclohexyl-1-[6-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]piperidin-4-amine;N-cyclohexyl-1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]piperidin-4-amine;2-[[1-[6-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]piperidin-4-yl]amino]cyclohexan-1-ol;1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]-N-(oxan-4-yl)piperidin-4-amine;2-[[1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]piperidin-4-yl]amino]cyclohexan-1-ol?
The IUPAC name of N-cyclohexyl-1-[6-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]piperidin-4-amine;N-cyclohexyl-1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]piperidin-4-amine;2-[[1-[6-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]piperidin-4-yl]amino]cyclohexan-1-ol;1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]-N-(oxan-4-yl)piperidin-4-amine;2-[[1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]piperidin-4-yl]amino]cyclohexan-1-ol (CID 158330098) is N-cyclohexyl-1-[6-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]piperidin-4-amine;N-cyclohexyl-1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]piperidin-4-amine;2-[[1-[6-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]piperidin-4-yl]amino]cyclohexan-1-ol;1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]-N-(oxan-4-yl)piperidin-4-amine;2-[[1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]piperidin-4-yl]amino]cyclohexan-1-ol.
What is the SMILES notation for N-cyclohexyl-1-[6-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]piperidin-4-amine;N-cyclohexyl-1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]piperidin-4-amine;2-[[1-[6-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]piperidin-4-yl]amino]cyclohexan-1-ol;1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]-N-(oxan-4-yl)piperidin-4-amine;2-[[1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]piperidin-4-yl]amino]cyclohexan-1-ol?
The canonical SMILES for N-cyclohexyl-1-[6-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]piperidin-4-amine;N-cyclohexyl-1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]piperidin-4-amine;2-[[1-[6-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]piperidin-4-yl]amino]cyclohexan-1-ol;1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]-N-(oxan-4-yl)piperidin-4-amine;2-[[1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]piperidin-4-yl]amino]cyclohexan-1-ol is Cc1ccc2nc(N3CCC(NC4CCCCC4)CC3)c(-c3nc(C)no3)cc2c1.Cc1ccc2nc(N3CCC(NC4CCCCC4O)CC3)c(-c3nc(C)no3)cc2c1.Cc1noc(-c2cc3ccccc3nc2N2CCC(NC3CCCCC3)CC2)n1.Cc1noc(-c2cc3ccccc3nc2N2CCC(NC3CCCCC3O)CC2)n1.Cc1noc(-c2cc3ccccc3nc2N2CCC(NC3CCOCC3)CC2)n1.
What is the InChIKey of N-cyclohexyl-1-[6-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]piperidin-4-amine;N-cyclohexyl-1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]piperidin-4-amine;2-[[1-[6-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]piperidin-4-yl]amino]cyclohexan-1-ol;1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]-N-(oxan-4-yl)piperidin-4-amine;2-[[1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]piperidin-4-yl]amino]cyclohexan-1-ol?
The InChIKey is GPWYPSHNSDGDIQ-UHFFFAOYSA-N. The full InChI is InChI=1S/C24H31N5O2.C24H31N5O.C23H29N5O2.C23H29N5O.C22H27N5O2/c1-15-7-8-20-17(13-15)14-19(24-25-16(2)28-31-24)23(27-20)29-11-9-18(10-12-29)26-21-5-3-4-6-22(21)30;1-16-8-9-22-18(14-16)15-21(24-25-17(2)28-30-24)23(27-22)29-12-10-20(11-13-29)26-19-6-4-3-5-7-19;1-15-24-23(30-27-15)18-14-16-6-2-3-7-19(16)26-22(18)28-12-10-17(11-13-28)25-20-8-4-5-9-21(20)29;1-16-24-23(29-27-16)20-15-17-7-5-6-10-21(17)26-22(20)28-13-11-19(12-14-28)25-18-8-3-2-4-9-18;1-15-23-22(29-26-15)19-14-16-4-2-3-5-20(16)25-21(19)27-10-6-17(7-11-27)24-18-8-12-28-13-9-18/h7-8,13-14,18,21-22,26,30H,3-6,9-12H2,1-2H3;8-9,14-15,19-20,26H,3-7,10-13H2,1-2H3;2-3,6-7,14,17,20-21,25,29H,4-5,8-13H2,1H3;5-7,10,15,18-19,25H,2-4,8-9,11-14H2,1H3;2-5,14,17-18,24H,6-13H2,1H3.
What are the key properties of N-cyclohexyl-1-[6-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]piperidin-4-amine;N-cyclohexyl-1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]piperidin-4-amine;2-[[1-[6-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]piperidin-4-yl]amino]cyclohexan-1-ol;1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]-N-(oxan-4-yl)piperidin-4-amine;2-[[1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]piperidin-4-yl]amino]cyclohexan-1-ol?
N-cyclohexyl-1-[6-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]piperidin-4-amine;N-cyclohexyl-1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]piperidin-4-amine;2-[[1-[6-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]piperidin-4-yl]amino]cyclohexan-1-ol;1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]-N-(oxan-4-yl)piperidin-4-amine;2-[[1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]piperidin-4-yl]amino]cyclohexan-1-ol has a molecular weight of 2019.62 g/mol, XLogP of 19.83, 20 rotatable bonds, 7 hydrogen bond donors, and 33 hydrogen bond acceptors.
Where does this data come from?
All data for N-cyclohexyl-1-[6-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]piperidin-4-amine;N-cyclohexyl-1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]piperidin-4-amine;2-[[1-[6-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]piperidin-4-yl]amino]cyclohexan-1-ol;1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]-N-(oxan-4-yl)piperidin-4-amine;2-[[1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]piperidin-4-yl]amino]cyclohexan-1-ol is sourced from PubChem (CID 158330098), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).